Following FDA approval of Pfizer's COVID-19 vaccine attention is turning to rollout and fears of some refusing to be immunized. These fears are particularly strong among minority communities, we ask why some of the hardest hit are still apprehensive about taking the vaccine. Dr. Georges Benjamin, the Executive Director of the American Public Health Association and Dr. Padmini Pillai of MIT weigh in.